Ads
related to: medications prescribed for lupus patients with arthritis list of names- Official HCP Resources
Download professional resources
for you and your practice.
- Starting Treatment
Get official info and learn how to
initiate treatment. See MOA info.
- Safety & Efficacy Data
View safety and efficacy profile
assessed in clinical trials.
- Lupus Nephritis Treatment
Info on an oral treatment option.
Learn more about treating LN.
- Official HCP Resources
goodrx.com has been visited by 100K+ users in the past month
"About 50% of US physicians advise patients consult GoodRx." - Fortune
Search results
Results from the WOW.Com Content Network
Belimumab, sold under the brand name Benlysta, is a human monoclonal antibody that inhibits B-cell activating factor (BAFF), [6] also known as B-lymphocyte stimulator (BLyS). [7] It is approved in the United States [8] and Canada, [9] and the European Union [5] to treat systemic lupus erythematosus and lupus nephritis. [10]
Furthermore, anti-histone antibodies can also be positive in drug-induced lupus. [citation needed] Anti-Histone antibodies are positive in up to 95% of patients with drug induced lupus. The most common medications associated with drug induced lupus are hydralazine, procainamide, isoniazid, methyldopa, chlorpromazine, quinidine, and minocycline. [9]
Azathioprine, sold under the brand name Imuran, among others, is an immunosuppressive medication. [5] It is used for the treatment of rheumatoid arthritis, granulomatosis with polyangiitis, Crohn's disease, ulcerative colitis, and systemic lupus erythematosus; and in kidney transplants to prevent rejection.
Leflunomide, sold under the brand name Arava among others, is an immunosuppressive disease-modifying antirheumatic drug , [8] used in active moderate-to-severe rheumatoid arthritis and psoriatic arthritis. It is a pyrimidine synthesis inhibitor that works by inhibiting dihydroorotate dehydrogenase. [9] Bottle of Leflunomide (Arava) and tablet
TNF-α Inhibitors are the most commonly prescribed medication among biologic response modifiers used to treat arthritis. Patients with rheumatic conditions may have higher levels of TNF in the systemic circulation. [18] As a result of increased levels of TNF, there would be more inflammation and persistent symptoms of arthritis. [18]
Current lupus treatments can vary, but options include anti-inflammatory drugs, corticosteroids, immunosuppressants, and biologic medications, the NIAMS says. But this research could change that.